Sidoti Downgrades Exactech Inc (EXAC) to Neutral Following Acquisition

Go back to Sidoti Downgrades Exactech Inc (EXAC) to Neutral Following Acquisition

Baird Downgrades Exactech Inc (EXAC) to Neutral Following Acquisition

October 23, 2017 10:19 AM EDT

Baird downgraded Exactech Inc (NASDAQ: EXAC) from Outperform to Neutral with a price target of $42.00 (from $34.00).

For an analyst ratings summary and ratings history on Exactech Inc click here. For more ratings news on Exactech Inc click here.

Shares of Exactech Inc closed at $32.00 Friday.

... More

Exactech (EXAC) to Go Private in $625 Million Deal with TPG Capital

October 23, 2017 8:16 AM EDT

Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that it has entered into a definitive merger agreement under which TPG Capital, the global private equity platform of alternative asset firm TPG, will acquire all of the outstanding shares of Exactech common stock. Exactechs board of directors approved the agreement which provides for the payment of $42.00 per share in cash to all holders of Exactech common stock other than certain management stockholders who have agreed to exchange a portion of... More